Capital International Investors boosted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,892,745 shares of the company’s stock after acquiring an additional 243,487 shares during the period. Capital […]

Capital International Investors lifted its position in SLB Limited (NYSE:SLB – Free Report) by 86.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,627,072 shares of the oil and gas company’s stock after purchasing an additional 5,404,948 shares during the quarter. […]

Capital International Investors increased its stake in British American Tobacco p.l.c. (NYSE:BTI – Free Report) by 0.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,389,481 shares of the company’s stock after acquiring an additional 332,062 shares during the period. Capital International Investors’ holdings in British […]

Capital International Investors lessened its holdings in Toast, Inc. (NYSE:TOST – Free Report) by 6.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 45,391,459 shares of the company’s stock after selling 3,036,601 shares during the quarter. Capital International Investors owned approximately 0.09% of Toast […]

Capital International Investors lowered its stake in Equifax, Inc. (NYSE:EFX – Free Report) by 38.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,438,868 shares of the credit services provider’s stock after selling 3,995,916 shares during the quarter. Capital International Investors owned 0.05% of Equifax worth […]